Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications

被引：0
作者：
Jillan Cantor Sackett
Ronald A. Weller
Elizabeth B. Weller
机构：
[1] Thomas Jefferson University Hospital,Department of Psychiatry
来源：
Current Psychiatry Reports | 2009年 / 11卷
关键词：
Pregnant Woman; Major Depressive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitor; Maternal Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This paper reviews the risks and benefits of using selective serotonin reuptake inhibitors (SSRIs) in pregnant women. The effects of SSRI use on pregnant women and fetuses are discussed, and the need for SSRI treatment is explained. Persistent pulmonary hypertension of the newborn, teratogenic risks of SSRI treatment during pregnancy, neonatal adaptations, and long-term outcomes for children whose mothers used SSRIs during pregnancy are specifically considered. Due to conflicting results from current studies, there are no clear guidelines for SSRI treatment in pregnancy. Patients and doctors must discuss together the risks and benefits of SSRI use during pregnancy and decide on a course of treatment. Potential risks must be balanced against the effects of untreated maternal depression.
引用
收藏
页码：253 / 257
页数：4
相关论文
共 50 条
[31]   Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation [J].
Levent Ozcan ;
Emre Can Polat ;
Alper Otunctemur ;
Emin Ozbek .
International Urology and Nephrology, 2015, 47 :283-287
[32]   Selective serotonin reuptake inhibitor-induced akathisia [J].
Koliscak, Lindsey P. ;
Makela, Eugene H. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (02) :E28-E38
[33]   Is the selective serotonin reuptake inhibitor fluoxetine a fountain of youth? [J].
Quinlan, Elizabeth M. .
FUTURE NEUROLOGY, 2008, 3 (04) :385-389
[34]   Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births [J].
Gao, Shan-Yan ;
Wu, Qi-Jun ;
Sun, Ce ;
Zhang, Tie-Ning ;
Shen, Zi-Qi ;
Liu, Cai-Xia ;
Gong, Ting-Ting ;
Xu, Xin ;
Ji, Chao ;
Huang, Dong-Hui ;
Chang, Qing ;
Zhao, Yu-Hong .
BMC MEDICINE, 2018, 16
[35]   Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma [J].
Chen, Hsin-Yi ;
Lin, Cheng-Li ;
Lai, Shih-Wei ;
Kao, Chia-Hung .
JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (06) :E692-E696
[36]   Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development [J].
Xu, YL ;
Sari, Y ;
Zhou, FC .
DEVELOPMENTAL BRAIN RESEARCH, 2004, 150 (02) :151-161
[37]   Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality [J].
Domingues, Rafael R. ;
Fricke, Hannah P. ;
Sheftel, Celeste M. ;
Bell, Autumn M. ;
Sartori, Luma C. ;
Manuel, Robbie S. J. ;
Krajco, Chandler J. ;
Wiltbank, Milo C. ;
Hernandez, Laura L. .
TOXICS, 2022, 10 (01)
[38]   Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome [J].
Klinger, G. ;
Frankenthal, D. ;
Merlob, P. ;
Diamond, G. ;
Sirota, L. ;
Levinson-Castiel, R. ;
Linder, N. ;
Stahl, B. ;
Inbar, D. .
JOURNAL OF PERINATOLOGY, 2011, 31 (09) :615-620
[39]   Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome [J].
G Klinger ;
D Frankenthal ;
P Merlob ;
G Diamond ;
L Sirota ;
R Levinson-Castiel ;
N Linder ;
B Stahl ;
D Inbar .
Journal of Perinatology, 2011, 31 :615-620
[40]   Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder [J].
Wu, Eric Q. ;
Yu, Andrew P. ;
Lauzon, Veronique ;
Ramakrishnan, Karthik ;
Marynchenko, Maryna ;
Ben-Hamadi, Rym ;
Blum, Steven ;
Erder, M. Haim .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) :441-451
12345